Table 2 Clinical data

Mood stabilizers

 Lithium

30%

–

 Atypical antipsychotics

35%

–

 Anticonvulsants

10%

–

 Others

25%

–

Somatic comorbidities

 Cardiovascular disease

5

0

χ²(1) = 5.71, p = 0.017^a

 Diabetes mellitus

3

0

χ²(1) = 3.24, p = 0.231^a

 Obstructive pulmonary disease

2

0

χ²(1) = 2.11, p = 0.487^a

 Hypertension

6

2

χ²(1) = 2.50, p = 0.114

Symptom self-ratings

 BDI-2 (M, SD), April

15.45 (10.74)

3.10 (2.53)

t(38) = 5.00, p < 0.001

 BDI-2 (M, SD), May

12.20 (11.69)

2.40 (2.21)

t(38) = 3.69, p < 0.01

 ASRM (M, SD), April

0.95 (2.28)

0.55 (1.19)

t(38) = 0.70, p = 0.491

 ASRM (M, SD), May

1.5 (2.19)

0.25 (0.55)

t(38) = 2.48, p = 0.022